Christopher T Longenecker, Kelley A Jones, Corrilynn O Hileman, Nwora Lance Okeke, Barbara M Gripshover, Angela Aifah, Gerald S Bloomfield, Charles Muiruri, Valerie A Smith, Rajesh Vedanthan, Allison R Webel, Hayden B Bosworth
IMPORTANCE: Despite higher atherosclerotic cardiovascular disease (ASCVD) risk, people with HIV (PWH) experience unique barriers to ASCVD prevention, such as changing models of HIV primary care. OBJECTIVE: To test whether a multicomponent nurse-led strategy would improve systolic blood pressure (SBP) and non-high-density lipoprotein (HDL) cholesterol level in a diverse population of PWH receiving antiretroviral therapy (ART). DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial enrolled PWH at 3 academic HIV clinics in the US from September 2019 to January 2022 and conducted follow-up for 12 months until January 2023...
March 4, 2024: JAMA Network Open